OrthoLite Expands Sales Team, Focuses on Partnership Development

My Subscriptions

Payment Confirmation

Transaction Failed

Your transaction failed, please try again or contact site support.

October 19, 2017

OrthoLite announces the hire of Larry O’Brien as Key Account Sales Manager.

After a 27-year tenure at Nike, O’Brien will help OrthoLite further strengthen and expand upon the company’s long-time partnership with Nike across all categories. O’Brien will be working out of the OrthoLite Portland Sales Office.

C.B. Tuite, SVP of Sales and Marketing, OrthoLite. commented, “We are thrilled to have Larry join our sales team.  His relationships at Nike, both in the U.S. and Asia, combined with an extensive product development background will add tremendous value to our leadership positioning in the athletic category and also reinforce our collaborative role with each of our valued brand partners.”

O’Brien started his career as a Nike Store Manager, then as an EKIN Technical Representative before moving into Product Development where he became very familiar with OrthoLite. He was the former Senior Product Training Specialist where he trained other Product Developers when they were hired by Nike and in recent years was a Product Developer in their Young Athletes business unit.

American owned and operated, OrthoLite insoles retain all attributes such as long lasting cushioning, unmatched breathability and moisture management for the lifetime of a shoe. These factors drive continued brand loyalty and improved sell-through for more than 250 shoe brands. To ensure the highest product quality, OrthoLite is a totally vertically integrated insole manufacturing facility as well as a chemical systems-house producing proprietary open cell polyurethane formulations. OrthoLite has sales offices in the United States, Vietnam, Asia and Europe as well as manufacturing facilities in China, Vietnam and Indonesia.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.